NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
Back to search
Official data from USPTO
CONCIEO PHARMA, LLC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONCIEO PHARMA, LLC
ST13
US500000097098251Class
1, 5, 40
Filing
97098251
Registration
7140342
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/15/2023
Trademark type
Word
Nice classes
1, 5, 40
Filing date
10/28/2021
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
08/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/11/2023
First use in commerce
04/11/2023
Drawing code
4
Owner type
16
Owner location
Memphis, TN
Examiner
CHADAB, SETH WILLIG
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Concieo Pharma, LLC
Representatives
Cecilia S. Barnes
Technical classification
Nice Classes
Class 1Class 5Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancerinfectious diseasesautoimmune disorderscardiovascular diseasesblood disordersneurologic disordersskin diseasesmusculoskeletal disordersgenetic disordersdigestive disordersdiabetes-related conditionseye conditionsviraltransplants
Class 5
Pharmaceutical preparations for the treatment of cancerinfectious diseasesautoimmune disorderscardiovascular diseasesblood disordersneurologic disordersskin diseasesmusculoskeletal disordersgenetic disordersdigestive disordersdiabetes-related conditionseye conditionsviraltransplants
Class 40
Custom manufacture of active pharmaceutical ingredientschemical compoundsbiologicals for pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/12/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/11/2023
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
07/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2023
GNRT
NON-FINAL ACTION E-MAILED
06/12/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/17/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/17/2023
IUAF
USE AMENDMENT FILED
04/27/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/27/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/10/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/10/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/10/2022
DOCK
ASSIGNED TO EXAMINER
08/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2021
NWAP
NEW APPLICATION ENTERED
11/01/2021
Continuous trademark protection
Get notified about every new filing that threatens CONCIEO PHARMA, LLC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.